Vyvanse has been approved by the Food and Drug Administration to treat Attention Deficit Hyperactivity Disorder (ADHD) for children six years old to twelve years old. This medication has not been tested in children under the age of six and should not be given to children five and under.
Vyvanse is a short acting medication Normally, the first dose of Vyvanse is taken first thing in the morning. Additional doses can...
Read moreAnxiety causes constant worrying and fear. It is estimated that one fourth of people with ADHD also suffer from some type of anxiety... Read more »
During the next few weeks, as the holiday season pushes you to your limits with activities, events and a growing to-do list, the effects of... Read more »
My son Lawrence started kindergarten last year. It was kind of tough on him. The class was three hours long, and they only had a short, ten... Read more »
Anxiety and ADHD, Attention Deficit Hyperactivity Disorder, often are co-existing conditions. ADHD is a psychological condition. The... Read more »
As my son grows and develops, certain challenges become a barrier to his happiness and success, and other challenges fade or diminish. How... Read more »
A new study by the maker of Vyvanse found that the medication controlled attention- deficit/hyperactivity disorder symptoms in children 6 to 12 years... Read more »
This study will evaluate the optimal dosing of Vyvanse in kids with attention-deficit/hyperactivity disorder. Researchers want to know the efficacy,... Read more »
Vyvanse is effective in treating adults with attention-deficit/hyperactivity disorder, according to new clinical trial results. In the study, 414... Read more »
The U.S. Food and Drug Administration has approved Vyvanse for the treatment of attention-deficit/hyperactivity disorder in adults. Vyvanse is a new... Read more »
ADHD and Anxiety are considered to be common co-existing conditions. Stimulant medications, frequently used to treat ADHD, can exacerbate symptoms of... Read more »